Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 09-May-24
Select bar for recommendation details.
Recommendations | 09-May-24 | |
---|---|---|
Buy | 0 | |
Outperform | 1 | |
Hold | 0 | |
Underperform | 1 | |
Sell | 0 |
Share price forecast in NZD
The 2 analysts offering 12 month price targets for AFT Pharmaceuticals Ltd have a median target of 3.70, with a high estimate of 4.60 and a low estimate of 2.80. The median estimate represents a 30.28% increase from the last price of 2.84.
High | 62.0% | 4.60 |
Med | 30.3% | 3.70 |
Low | -1.4% | 2.80 |
Dividends
Div growth (TTM) | -- |
---|
More ▼
Earnings history & estimates in NZD
Average growth rate | +83.29% |
More ▼
Revenue history & estimates in NZD
Average growth rate | +16.64% |
More ▼